Answers are grounded in this paper and cite their sources.
Objective Recent research finds that a significant share of long-acting reversible contraceptive (LARC) users with private insurance incur out-of-pocket costs associated with contraceptive services and supplies, despite the Affordable Care Act's (ACA) requirement that contraceptives be covered without cost-sharing. This analysis aimed to advance our understanding of what contributes to the out-pocket costs for intrauterine device (IUD) and contraceptive implant insertions by looking at all services and costs associated with insertion among privately insured individuals. Study Design Using the 2023 Merative MarketScan Commercial Claims and Encounter Database, a national sample of healthcare claims for people enrolled in employer sponsored insurance plans, we estimated out-of-pocket costs for 98,916 IUD and 30,259 implant insertion encounters among females ages 15-49. Results Only 2.4% of IUD and 4.0% of implant insertion encounters had out-of-pocket costs related to the LARC device or insertion procedure itself. However, we find that nearly half of IUD (45.7%) and over a third of implant (35.8%) insertion encounters resulted in out-of-pocket expenses for other services commonly provided as part of a LARC insertion, such as pregnancy tests, office visits, ultrasounds, STI tests, and pain medication. Among insertion encounters with cost-sharing, the median out-of-pocket cost was $35.00 (25 th – 75 th percentile: $15.00 - $90.00) for an IUD insertion and $16.88 (25 th – 75 th percentile: $7.75 - $40.00) for an implant insertion. Conclusion Despite a federal requirement that insurance cover the full cost of contraceptive services and supplies, a sizable share of IUD and contraceptive implant insertions result in out-of-pocket charges for privately insured patients. Implications While privately insured women rarely pay out-of-pocket for a LARC device or insertion procedure itself, other services commonly provided as part of the LARC insertion often result in out-of-pocket costs, highlighting areas for clearer guidance, stronger oversight, and better patient and provider education on coverage of services related to LARC provision.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: